Form D · Other Technology
Pike Therapeutics Inc.
Vancouver, A1 · CIK 0001884336
Offering snapshot reported Jul 21, 2026 · SEC filing
- Reported sold
- $760K Offering amount: $760K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2026 | Initial | $760,000 | No comparison | 5 | SEC filing |
| Sep 5, 2023 | Initial | $100,000 | No comparison | 2 | SEC filing |
| Sep 24, 2021 | Initial | $174,999 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-591557
Source: Form D, filed Jul 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian Fodie | Director, Executive |
| Bradley Miles | Director, Executive |
| Mark Purdy | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
20 Th Floor, 250 Howe Street
Vancouver, A1, V6C 3R8
Vancouver, A1, V6C 3R8